gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · AIFFTechnologyPackaged Software

Firefly Neuroscience, Inc. Common Stock (AIFF)

$0.9901−0.18%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$0.99▼ 45.90% in range
Nov 3, 2025Low $0.64 · High $3.02Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026

Firefly Neuroscience closed at $0.99 on Nov 3, down 0.18%, 67.2% below its 52-week closing high. Volume of 21.4K shares was 0.16× its 20-day average (below normal).

Split-adjusted performance: -23.8% over one month, -51.9% over six months, -47.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $514K, up 71.9% from a year earlier, with a net margin of -386.0%.

Short interest was 751.2K shares at the Oct 15 settlement, down 31.6% from the prior report (5.1% of float, 2.9 days to cover).

Market cap$15.5M15.7M shares
Revenue · quarter$514.0K+71.9% YoY
Diluted EPS$-0.10—
P/E · TTM—P/S 8.6×
Net margin-386.0%Gross 49.2%
Dividend yieldNone
52-week range0.64 – 3.02−67.2% from high
Volume21.4K0.16× 20-day avg
Volatility · 60d143.9%Annualised
Short % of float5.1%2.9 days to cover
Net cash$9.2MCash $9.2M
Next earnings—Not scheduled
Split-adjusted performance
1W −0.9%1M −23.8%3M −13.9%6M −51.9%YTD +13.2%1Y −47.1%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Packaged Software

Percentile among 172 companies (100 = best)

6-month momentum8
Revenue growth95
Net margin7
Value (low P/E)—
Size11

Industry medians: 6-month return +16.9%, revenue growth +13.2%, net margin 1.4%, P/E 42.3×.

Short interest

Details →
Shares short751.2K−31.6% vs prior
Days to cover2.9Settled Oct 15
% of float5.1%
Short vol. 10d49.3%of daily volume

Closest peers by size in Packaged Software

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
AIFFFirefly Neuroscience$0.9901−0.18%−51.9%+71.9%−386.0%—$15.5M
IDAIT Stamp$2.57−0.39%+0.4%+10.7%−299.3%—$14.6MCompare
VIDAVIDA Global$0.9599+2.87%——−484.2%—$14.0MCompare
EXYNExyn Technologies$2.31−0.38%——−726.0%—$18.3MCompare
INLXIntellinetics$4.15+1.72%−40.7%−1.6%−27.5%—$18.7MCompare
SMSISmith Micro Software$2.310.00%−48.3%−1.8%−63.0%—$12.9MCompare
SNALSnail$2.20+0.92%−24.0%−11.3%−15.5%—$19.7MCompare
UPLDUpland Software$4.10+2.50%−55.9%−7.9%−75.0%—$12.1MCompare
AWREAware$0.9399+3.29%−24.8%−13.9%−17.9%—$20.6MCompare

News about Firefly Neuroscience

All news →
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan VolumesGlobeNewswire Inc. · Aug 5, 2026▲ PositiveFirefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective PeptidesGlobeNewswire Inc. · Jul 28, 2026▲ Positive

Quick answers

What does Firefly Neuroscience do?
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders.
What is AIFF's market cap?
$15.53M, based on the Nov 3 close of $0.99.
Does Firefly Neuroscience pay a dividend?
No regular cash dividend has been paid in the last year.
How much of AIFF is sold short?
751.2K shares, 5.1% of float, as of Oct 15, 2026.
What sector is AIFF in?
Technology, in the Packaged Software industry.

About Firefly Neuroscience

Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.

HQ: Kenmore, NY17 employeesListed Aug 13, 2024fireflyneuro.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology